CUE-102
WT1‑positive tumors (booster)
Phase 1Active
Key Facts
About ImmunoScape
A Singapore biotech delivering next‑generation TCR‑T cell therapies via a seed‑and‑boost platform for solid‑tumor oncology.
View full company profileWT1‑positive tumors (booster)
A Singapore biotech delivering next‑generation TCR‑T cell therapies via a seed‑and‑boost platform for solid‑tumor oncology.
View full company profile